Distinct claudin expression profiles of hepatocellular carcinoma and metastatic colorectal and pancreatic carcinomas

Journal of Histochemistry and Cytochemistry

Volumn 61, Issue 4, 2013, Pages 294-305

  Holczbauer, Ágnes ^a   Gyöngyösi, Benedek ^a   Lotz, Gábor ^a   Szijártó, Attila ^b   Kupcsulik, Péter ^b   Schaff, Zsuzsa ^a   Kiss, András ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b 1st Department of Pathology   (Hungary)

Author keywords

Claudins; Hepatocellular carcinoma; Liver metastasis; Tight junction

Indexed keywords

BETA ACTIN; CLAUDIN 1; CLAUDIN 2; CLAUDIN 3; CLAUDIN 4; CLAUDIN 7; MESSENGER RNA; CLAUDIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CELLULAR DISTRIBUTION; COLORECTAL CARCINOMA; COLORECTAL LIVER METASTASIS; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS METASTASIS; PANCREATIC LIVER METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; COLORECTAL TUMOR; GENETICS; LIVER TUMOR; METASTASIS; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY;

AGED; CARCINOMA, HEPATOCELLULAR; CLAUDINS; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION;

MLCS; MLOWN;

EID: 84878954671     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/0022155413479123     Document Type: Article

References (68)

1. Aung P.P., Mitani Y, Sanada Y, Nakayama H, Matsusaki K, Yasui W. 2006. Differential expression of claudin-2 in normal human tissues and gastrointestinal carcinomas. Virchows Arch. 448:428-434.
2. Balda M.S., Matter K. 2009. Tight junctions and the regulation of gene expression. Biochim Biophys Acta. 1788:761-767.
3. Borka K., Kaliszky P, Szabo E, Lotz G, Kupcsulik P, Schaff Z, Kiss A. 2007. Claudin expression in pancreatic endocrine tumors as compared with ductal adenocarcinomas. Virchows Arch. 450:549-557.
4. Borlak J., Meier T, Halter R, Spanel R, Spanel-Borowski K. 2005. Epidermal growth factor-induced hepatocellular carcinoma: gene expression profiles in precursor lesions, early stage and solitary tumours. Oncogene. 24:1809-1819.
5. Bornholdt J., Friis S, Godiksen S, Poulsen SS, Santoni-Rugiu E, Bisgaard HC, Lothe IM, Ikdahl T, Tveit KM, Johnson E, et al. 2011. The level of claudin-7 is reduced as an early event in colorectal carcinogenesis. BMC Cancer. 11:65.
6. Centeno BA. 2006. Pathology of liver metastases. Cancer Control. 13:13-26.
7. Chao Y.C., Pan SH, Yang SC, Yu SL, Che TF, Lin CW, Tsai MS, Chang G.C., Wu CH, Wu YY, et al. 2009. Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma. Am J Respir Crit Care Med. 179:123-133.
8. Chen J.S., Chen KT, Fan CW, Han CL, Chen YJ, Yu JS, Chang YS, Chien CW, Wu CP, Hung RP, et al. 2010. Comparison of membrane fraction proteomic profiles of normal and cancerous human colorectal tissues with gel-assisted digestion and iTRAQ labeling mass spectrometry. FEBS J. 277:3028-3038.
9. Cheung I.D., Bagnat M, Ma TP, Datta A, Evason K, Moore JC, Lawson N.D., Mostov KE, Moens CB, Stainier DY. 2012. Regulation of intrahepatic biliary duct morphogenesis by Claudin 15-like b. Dev Biol. 361:68-378.
10. Christofori G. 2006. New signals from the invasive front. Nature. 441:444-450.
11. Darido C., Buchert M, Pannequin J, Bastide P, Zalzali H, Mantamadiotis T, Bourgaux JF, Garambois V, Jay P, Blache P, et al. 2008. Defective claudin-7 regulation by Tcf-4 and Sox-9 disrupts the polarity and increases the tumorigenicity of colorectal cancer cells. Cancer Res. 68:4258-4268.
12. de Oliveira SS, de Oliveira IM, De Souza W, Morgado-Diaz JA. 2005. Claudins upregulation in human colorectal cancer. FEBS Lett. 579:6179-6185.
13. Dhawan P., Singh AB, Deane NG, No Y, Shiou SR, Schmidt C, Neff J., Washington MK, Beauchamp RD. 2005. Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest. 115:1765-1776.
14. Ersoz S., Mungan S, Cobanoglu U, Turgutalp H, Ozoran Y. 2011. Prognostic importance of Claudin-1 and Claudin-4 expression in colon carcinomas. Pathol Res Pract. 207:285-289.
15. Geller S.A., Dhall D, Alsabeh R. 2008. Application of immunohistochemistry to liver and gastrointestinal neoplasms: liver, stomach, colon, and pancreas. Arch Pathol Lab Med. 132:490-499.
16. Georges R., Bergmann F, Hamdi H, Zepp M, Eyol E, Hielscher T, Berger MR, Adwan H. 2012. Sequential biphasic changes in claudin1 and claudin4 expression are correlated to colorectal cancer progression and liver metastasis. J Cell Mol Med. 16:260-272.
17. Grone J., Weber B, Staub E, Heinze M, Klaman I, Pilarsky C, Hermann K, Castanos-Velez E, Ropcke S, Mann B, et al. 2007. Differential expression of genes encoding tight junction proteins in colorectal cancer: frequent dysregulation of claudin-1,-8 and-12. Int J Colorectal Dis. 22:651-659.
18. Hadj-Rabia S, Baala L, Vabres P, Hamel-Teillac D, Jacquemin E, Fabre M., Lyonnet S, De Prost Y, Munnich A, Hadchouel M, et al. 2004. Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: a tight junction disease. Gastroenterology. 127:1386-1390.
19. Higashi Y., Suzuki S, Sakaguchi T, Nakamura T, Baba S, Reinecker HC, Nakamura S, Konno H. 2007. Loss of claudin-1 expression correlates with malignancy of hepatocellular carcinoma. J Surg Res. 139:68-76.
20. Huang G.W., Ding X, Chen SL, Zeng L. 2011. Expression of claudin 10 protein in hepatocellular carcinoma: impact on survival. J Cancer Res Clin Oncol. 137:1213-1218.
21. Huo Q., Kinugasa T, Wang L, Huang J, Zhao J, Shibaguchi H, Kuroki M., Tanaka T, Yamashita Y, Nabeshima K, et al. 2009. Claudin-1 protein is a major factor involved in the tumorigenesis of colorectal cancer. Anticancer Res. 29:851-857.
22. Ip Y.C., Cheung ST, Lee YT, Ho JC, Fan ST. 2007. Inhibition of hepatocellular carcinoma invasion by suppression of claudin-10 in HLE cells. Mol Cancer Ther. 6:2858-2867.
23. Kadry Z., Malekkiani N, Clavien PA. 2001. Treatment of primary and secondary liver malignancy. Swiss Med Wkly. 131:338-345.
24. Kaihara T., Kawamata H, Imura J, Fujii S, Kitajima K, Omotehara F, Maeda N, Nakamura T, Fujimori T. 2003. Redifferentiation and ZO-1 reexpression in liver-metastasized colorectal cancer: possible association with epidermal growth factor receptor-induced tyrosine phosphorylation of ZO-1. Cancer Sci. 94:166-172.
25. Kim T.H., Huh JH, Lee S, Kang H, Kim GI, An HJ. 2008. Downregulation of claudin-2 in breast carcinomas is associated with advanced disease. Histopathology. 53:48-55.
26. Kinugasa T., Huo Q, Higashi D, Shibaguchi H, Kuroki M, Tanaka T, Futami K, Yamashita Y, Hachimine K, Maekawa S, et al. 2007. Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer. Anticancer Res. 27:3729-3734.
27. Kominsky S.L., Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A., Sauter G, Kallioniemi OP, Sukumar S. 2003. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene. 22:2021-2033.
28. Kuhn S., Koch M, Nubel T, Ladwein M, Antolovic D, Klingbeil P, Hildebrand D, Moldenhauer G, Langbein L, Franke WW, et al. 2007. A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression. Mol Cancer Res. 5:553-567.
29. Kwak P.B., Iwasaki S, Tomari Y. 2010. The microRNA pathway and cancer. Cancer Sci. 101:2309-2315.
30. Laurila J.J., Karttunen T, Koivukangas V, Laurila PA, Syrjala H, Saarnio J., Soini Y, Ala-Kokko TI. 2007. Tight junction proteins in gallbladder epithelium: different expression in acute acalculous and calculous cholecystitis. J Histochem Cytochem. 55:567-573.
31. Lioni M., Brafford P, Andl C, Rustgi A, El-Deiry W, Herlyn M, Smalley KS. 2007. Dysregulation of claudin-7 leads to loss of E-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells. Am J Pathol. 170:709-721.
32. Lódi C., Szabo E, Holczbauer A, Batmunkh E, Szijarto A, Kupcsulik P, Kovalszky I, Paku S, Illyes G, Kiss A, et al. 2006. hepatocellular carcinomas. Mod Pathol. 19:460-469.
33. Long H., Crean CD, Lee WH, Cummings OW, Gabig TG. 2001. Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res. 61:7878-7881.
34. Martin T.A., Jiang WG. 2009. Loss of tight junction barrier function and its role in cancer metastasis. Biochim Biophys Acta. 1788:872-891.
35. Meertens L., Bertaux C, Cukierman L, Cormier E, Lavillette D, Cosset F.L., Dragic T. 2008. The tight junction proteins claudin-1,-6, and-9 are entry cofactors for hepatitis C virus. J Virol. 82:3555-3560.
36. Merikallio H., Kaarteenaho R, Paakko P, Lehtonen S, Hirvikoski P, Makitaro R., Harju T, Soini Y. 2011. Zeb1 and twist are more commonly expressed in metastatic than primary lung tumours and show inverse associations with claudins. J Clin Pathol. 64:136-140.
37. Michl P., Barth C, Buchholz M, Lerch MM, Rolke M, Holzmann KH, Menke A, Fensterer H, Giehl K, Lohr M, et al. 2003. Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res. 63:6265-6271.
38. Mineta K., Yamamoto Y, Yamazaki Y, Tanaka H, Tada Y, Saito K, Tamura A., Igarashi M, Endo T, Takeuchi K, et al. 2011. Predicted expansion of the claudin multigene family. FEBS Lett. 585:606-612.
39. Miwa N., Furuse M, Tsukita S, Niikawa N, Nakamura Y, Furukawa Y. 2001. Involvement of claudin-1 in the beta-catenin/ Tcf signaling pathway and its frequent upregulation in human colorectal cancers. Oncol Res. 12:469-476.
40. Moldvay J., Jackel M, Paska C, Soltesz I, Schaff Z, Kiss A. 2007. Distinct claudin expression profile in histologic subtypes of lung cancer. Lung Cancer. 57:159-167.
41. Nakayama F., Semba S, Usami Y, Chiba H, Sawada N, Yokozaki H. 2008. Hypermethylation-modulated downregulation of claudin-7 expression promotes the progression of colorectal carcinoma. Pathobiology. 75:177-185.
42. Neesse A., Griesmann H, Gress TM, Michl P. 2012. Claudin-4 as therapeutic target in cancer. Arch Biochem Biophys. 524: 64-70.
43. Nemeth Z., Szasz AM, Tatrai P, Nemeth J, Gyorffy H, Somoracz A, Szijarto A, Kupcsulik P, Kiss A, Schaff Z. 2009. Claudin-1,-2,-3,-4,-7,-8, and-10 protein expression in biliary tract cancers. J Histochem Cytochem. 57:113-121.
44. Nichols L.S., Ashfaq R, Iacobuzio-Donahue CA. 2004. Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. Am J Clin Pathol. 121:226-230.
45. Orbán E., Szabo E, Lotz G, Kupcsulik P, Paska C, Schaff Z, Kiss A. 2008. Different expression of occludin and ZO-1 in primary and metastatic liver tumors. Pathol Oncol Res. 14:299-306.
46. Oshima T., Kunisaki C, Yoshihara K, Yamada R, Yamamoto N, Sato T., Makino H, Yamagishi S, Nagano Y, Fujii S, et al. 2008. Reduced expression of the claudin-7 gene correlates with venous invasion and liver metastasis in colorectal cancer. Oncol Rep. 19:953-959.
47. Rangel L.B., Agarwal R, D'Souza T, Pizer ES, Alo PL, Lancaster WD, Gregoire L, Schwartz DR, Cho KR, Morin PJ. 2003. Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin Cancer Res. 9:2567-2575.
48. Resnick M.B., Konkin T, Routhier J, Sabo E, Pricolo VE. 2005. Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod Pathol. 18:511-518.
49. Sakaguchi T., Gu X, Golden HM, Suh E, Rhoads DB, Reinecker HC. 2002. Cloning of the human claudin-2 5′-flanking region revealed a TATA-less promoter with conserved binding sites in mouse and human for caudal-related homeodomain proteins and hepatocyte nuclear factor-1alpha. J Biol Chem. 277:21361-21370.
50. Sauer T., Pedersen MK, Ebeltoft K, Naess O. 2005. Reduced expression of Claudin-7 in fine needle aspirates from breast carcinomas correlate with grading and metastatic disease. Cytopathology. 16:193-198.
51. Soini Y. 2005. Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours. Histopathology. 46:551-560.
52. Soini Y. 2012. Tight junctions in lung cancer and lung metastasis: a review. Int J Clin Exp Pathol. 5:126-136.
53. Son S., Kojima T, Decaens C, Yamaguchi H, Ito T, Imamura M, Murata M., Tanaka S, Chiba H, Hirata K, et al. 2009. Knockdown of tight junction protein claudin-2 prevents bile canalicular formation in WIF-B9 cells. Histochem Cell Biol. 131:411-424.
54. Sonoda N., Furuse M, Sasaki H, Yonemura S, Katahira J, Horiguchi Y, Tsukita S. 1999. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: evidence for direct involvement of claudins in tight junction barrier. J Cell Biol. 147:195-204.
55. Suh Y., Yoon CH, Kim RK, Lim EJ, Oh YS, Hwang SG, An S, Yoon G, Gye MC, Yi JM, et al. 2012. Claudin-1 induces epithelialmesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells [published online November 19, 2012]. Oncogene. doi:10.1038/onc.2012.505.
56. Suzuki M., Kato-Nakano M, Kawamoto S, Furuya A, Abe Y, Misaka H., Kimoto N, Nakamura K, Ohta S, Ando H. 2009. Therapeutic antitumor efficacy of monoclonal antibody against Claudin-4 for pancreatic and ovarian cancers. Cancer Sci. 100:1623-1630.
57. Szabo I., Kiss A, Schaff Z, Sobel G. 2009. Claudins as diagnostic and prognostic markers in gynecological cancer. Histol Histopathol. 24:1607-1615.
58. Szasz A.M., Nemeth Z, Gyorffy B, Micsinai M, Krenacs T, Baranyai Z, Harsanyi L, Kiss A, Schaff Z, Tokes AM, et al. 2011. Identification of a claudin-4 and E-cadherin score to predict prognosis in breast cancer. Cancer Sci. 102:2248-2254.
59. Szekely E., Torzsok P, Riesz P, Korompay A, Fintha A, Szekely T, Lotz G., Nyirady P, Romics I, Timar J, et al. 2011. Expression of claudins and their prognostic significance in noninvasive urothelial neoplasms of the human urinary bladder. J Histochem Cytochem. 59:932-941.
60. Tabaries S., Dong Z, Annis MG, Omeroglu A, Pepin F, Ouellet V, Russo C., Hassanain M, Metrakos P, Diaz Z, et al. 2011. Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes. Oncogene. 30:1318-1328.
61. Tokes A.M., Kulka J, Paku S, Szik A, Paska C, Novak PK, Szilak L, Kiss A., Bogi K, Schaff Z. 2005. Claudin-1,-3 and-4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res. 7:R296-R305.
62. Torzsok P., Riesz P, Kenessey I, Szekely E, Somoracz A, Nyirady P, Romics I, Schaff Z, Lotz G, Kiss A. 2011. Claudins and ki-67: potential markers to differentiate low-and high-grade transitional cell carcinomas of the urinary bladder. J Histochem Cytochem. 59:1022-1030.
63. Tsukita S., Furuse M. 1999. Occludin and claudins in tight-junction strands: leading or supporting players? Trends Cell Biol. 9:268-273.
64. Ueda J., Semba S, Chiba H, Sawada N, Seo Y, Kasuga M, Yokozaki H. 2007. Heterogeneous expression of claudin-4 in human colorectal cancer: decreased claudin-4 expression at the invasive front correlates cancer invasion and metastasis. Pathobiology. 74:32-41.
65. Usami Y., Chiba H, Nakayama F, Ueda J, Matsuda Y, Sawada N, Komori T., Ito A, Yokozaki H. 2006. Reduced expression of claudin-7 correlates with invasion and metastasis in squamous cell carcinoma of the esophagus. Hum Pathol. 37:569-577.
66. Wang X., Tully O, Ngo B, Zitin M, Mullin JM. 2011. Epithelial tight junctional changes in colorectal cancer tissues. Sci World J. 11:826-841.
67. Yoon C.H., Kim MJ, Park MJ, Park IC, Hwang SG, An S, Choi YH, Yoon G., Lee SJ. 2010. Claudin-1 acts through c-Abl-protein kinase Cdelta (PKCdelta) signaling and has a causal role in the acquisition of invasive capacity in human liver cells. J Biol Chem. 285:226-233.
68. Zeng X., Lin Y, Yin C, Zhang X, Ning BF, Zhang Q, Zhang JP, Qiu L, Qin XR, Chen YX, et al. 2011. Recombinant adenovirus carrying the hepatocyte nuclear factor-1alpha gene inhibits hepatocellular carcinoma xenograft growth in mice. Hepatology. 54:2036-2047.